Minute Insight: Biocartis Launches Its Idylla 3-Hour Lung Cancer Test
Idylla can test for a range of markers relevant to the treatment of NSCLC and does so faster and more efficiently than some other testing technologies.
You may also be interested in...
The Memorial Sloan Kettering spin-out has received CE-IVD and UKCA marks for its artificial intelligence software designed to identify HER2 expression in biopsies.
Nothing except a name, but Creo Medical says its Speedboat Inject device can turn some surgeries from prolonged hospital stays into one-day visits.
In this episode of Report Digest, UK-based reporter Barnaby Pickering speaks to analyst Mike Carmody about Meddevicetracker’s recent report on deep brain and Vagus nerve stimulation. The two discuss market players, recent tech developments and future potential for the market.